Scotiabank maintains Sector Outperform rating on Amgen, $500 price target
Scotiabank maintained their Sector Outperform rating on Amgen's stock with a price target of $500.00.The price target implies an upside of 19.6% from the Sep 28 close of $418.13.Key takeaways from the analyst noteStrong Product Portfolio and Strategic Acquisitions: Amgen has a diverse and robust pr…